The U.S. Securities and Exchange Commission has hit former pharmaceutical executive and convicted stock fraudster Martin Shkreli with a sanction barring him from associating with brokers and ratings agencies.
Shkreli is serving a seven-year prison sentence for his conviction of two counts of securities fraud and related conspiracy count. He was convicted of running a scheme to defraud investors in two hedge funds he created, MSMB Healthcare and MSMB Capital Management.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]